- Home
- MPU vs ENTX Comparison
MPU vs ENTX Comparison
Compare MPU & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- ENTX
- Stock Information
- Founded
- MPU 1989
- ENTX 2010
- Country
- MPU Singapore
- ENTX Israel
- Employees
- MPU N/A
- ENTX N/A
- Industry
- MPU Transportation Services
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MPU Consumer Discretionary
- ENTX Health Care
- Exchange
- MPU Nasdaq
- ENTX Nasdaq
- Market Cap
- MPU 88.9M
- ENTX 82.2M
- IPO Year
- MPU 1998
- ENTX 2018
- Fundamental
- Price
- MPU $1.18
- ENTX $1.91
- Analyst Decision
- MPU
- ENTX Strong Buy
- Analyst Count
- MPU 0
- ENTX 1
- Target Price
- MPU N/A
- ENTX $10.00
- AVG Volume (30 Days)
- MPU 896.7K
- ENTX 50.8K
- Earning Date
- MPU 11-11-2025
- ENTX 11-07-2025
- Dividend Yield
- MPU N/A
- ENTX N/A
- EPS Growth
- MPU N/A
- ENTX N/A
- EPS
- MPU N/A
- ENTX N/A
- Revenue
- MPU $35,373,100.00
- ENTX $166,000.00
- Revenue This Year
- MPU N/A
- ENTX N/A
- Revenue Next Year
- MPU N/A
- ENTX N/A
- P/E Ratio
- MPU N/A
- ENTX N/A
- Revenue Growth
- MPU 126.64
- ENTX 191.23
- 52 Week Low
- MPU $0.49
- ENTX $1.50
- 52 Week High
- MPU $4.44
- ENTX $2.79
- Technical
- Relative Strength Index (RSI)
- MPU 33.97
- ENTX 53.16
- Support Level
- MPU $1.18
- ENTX $1.84
- Resistance Level
- MPU $1.36
- ENTX $1.93
- Average True Range (ATR)
- MPU 0.12
- ENTX 0.08
- MACD
- MPU 0.02
- ENTX 0.01
- Stochastic Oscillator
- MPU 6.00
- ENTX 68.18
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.